Combination therapy with rituximab, low-dose cyclophosphamide, and prednisone for idiopathic membranous nephropathy: a case series

BACKGROUND: Membranous nephropathy is a common cause of the nephrotic syndrome. Treatment with standard regimens fails to induce complete remission in most patients. We evaluated the efficacy of combination therapy with rituximab, low-dose, oral cyclophosphamide, and an accelerated prednisone taper...

Descripción completa

Detalles Bibliográficos
Autores principales: Cortazar, Frank B., Leaf, David E., Owens, Charles T., Laliberte, Karen, Pendergraft, William F., Niles, John L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5286562/
https://www.ncbi.nlm.nih.gov/pubmed/28143416
http://dx.doi.org/10.1186/s12882-017-0459-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5286562/
https://www.ncbi.nlm.nih.gov/pubmed/28143416
http://dx.doi.org/10.1186/s12882-017-0459-z

Ejemplares similares